Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gardasil
Pharma
With $640M in sales of Lagevrio, Merck bumps up revenue forecast
Merck's COVID antiviral treatment Lagevrio racked up sales of $640 million last quarter, shocking analysts who figured it would generate $120 million.
Kevin Dunleavy
Oct 26, 2023 10:55am
GSK partners up with Zhifei to market Shingrix in China
Oct 9, 2023 11:20am
Merck still eyeing M&A and has plenty of dealmaking firepower
Aug 1, 2023 11:25am
After recent moves, Merck no longer focused on Keytruda deadline
Apr 27, 2023 1:22pm
Merck doesn't expect immediate boost from Keytruda's last nod: CEO
Feb 2, 2023 11:24am
Merck CEO Davis touts potential of CV drug candidates
Oct 27, 2022 12:02pm